TIRZ 30mg

In lab rats, tirzepatide—a dual GLP-1 and GIP receptor agonist—promotes significant weight loss, lowers blood glucose, and reduces visceral fat. Furthermore, preclinical studies show it mitigates diabetes-induced cognitive impairment, offers cardioprotective effects, and heavily reduces voluntary alcohol consumption

FOR RESEARCH PURPOSES ONLY NOT FOR HUMAN CONSUMPTION